Search
News Archive
Categories
US launch of chitosan-soaked Tencel C fiber at upcoming Los Angeles Textile Show & Texworld USA
Posted On: March 16, 2011Textile World: Lenzing of Austria recently launched Tencel C, comprising Tencel fiber soaked with chitosan, made of chitin extracted from crab shells. Lenzing reports it adds skin-soothing cosmetic benefits to Tencel, and in a scientific wear study, stockings made with Tencel C were shown to protect the skin, allow it to retain more moisture, improve skin elasticity and stimulate skin cell regeneration. Lenzing is promoting the fiber for use in apparel worn next to the skin and in home furnishings such as bed sheets. There also are potential wound-healing applications.
“Our research team worked on Tencel C for almost ten years,” said Alexandra Steger, project manager marketing apparel, Textile Fibers, Lenzing AG. “We have attached the chitosan so that it can’t wash off or be stripped off. The fiber is spun, and the chitosan solution penetrates into its porous structure. The fiber is then finished. Cellulose and chitosan are very similar, so we can combine the botanic and oceanic stories,” she said, pointing out cellulose’s botanic source and chitosan’s oceanic source. “The molecules differ only at one point where chitosan has an amino group.
Lenzing will launch Tencel C in the United States at the upcoming Los Angeles International Textile Show and Texworld USA.
Worldwide largest closed algae production plant ready for production
Posted On: March 9, 2011After EADS and IGV together demonstrated the first flight with 100% algal fuel on the international air show ILA 2010, a further milestone was achieved in the development of algae mass cultivation for oil-production. On February 10, 2011 the algae production plant PBR 85.000 of the IGV GmbH Potsdam was handed over ready for production and accepted by the Spanish Aurantia-group.
The site is situated in the sun-drenched Andalusia in Southern Spain, near to Jerez. The photobioreactor PBR has a total volume of 85.000 liter and is therefore the world’s largest closed facility for the production of microalgae ever build and successfully brought into operation. In 35 kilometer glass tube on a footprint of 1.000 m², in which algae capture sunlight and efficiently photosynthesize, they generate energy rich oils which can be used in the production of fuels.
Aquapharm appoints new Senior Vice President
Posted On: March 9, 2011Aquapharm Biodiscovery Ltd., a leading Scottish marine biotechnology company, today announced the appointment of another prominent industry figure to its team.
Bertrand Lehuu, who has almost 30 years’ experience in senior roles in many of Europe’s biggest pharmaceutical and biotechnology companies, joins Aquapharm as Senior Vice President (SVP) -Pharma Business.
Bertrand is well known as a bio-pharmaceutical deal-maker and will be responsible for business development in this field for Aquapharm.
After gaining his Doctorate of Pharmacology from Paris University, Bertrand has built his career as a Business Development specialist in the Pasteur Institute, Flamel Technologies, F-Hoffmann La Roche Ltd., Basilea, Neuro3d, BioXell and most recently PharmaSwiss.
His new role at Aquapharm marks a return to the cutting-edge of biotechnology in a company focused on discovering and developing new pharmaceutical, personal care and nutritional products from its unique collection of marine micro-organisms.
Bertrand will play a strategic role in the development and future growth of the company which, in the last year alone, has attracted a significant amount of funding and struck several research partnerships.
2010 has seen Aquapharm go from strength-to-strength, securing £4.2 million of funding from existing investors Aescap Venture, Tate & Lyle Ventures, Highlands & Islands Enterprise and NESTA.
Highlighting the diversity and depth of its research, the company has also entered into a collaboration with Albany Molecular Research to identify novel anti-microbial and anti-inflammatory drug-candidates; Dundee University to develop compounds that may help in the fight against Alzheimer’s; and Leatherhead Food Research to identify food preservatives.
Today’s announcement of Aquapharm’s newest recruit is the latest in a series of prominent appointments, latterly that of Mats Pettersson who joined the Board in January this year. In 2010, serial biotech entrepreneur Prof. Simon Best joined the company as CEO, while Dr Tim Morley was named Chief Scientific Officer (CSO) and Aquapharm founder Dr Andrew Mearns Spragg moved to the role of Chief Technology Officer (CTO).
Source: Company release
Solazyme, Sephora and QVC Announce Agreements for the U.S. and International Launch of Solazyme’s New Anti-Aging Skincare Line, Algenist™
Posted On: March 9, 2011Solazyme, Inc., the leading industrial biotechnology company producing renewable oil and bioproducts from microalgae, has signed agreements with leading beauty retailer Sephora® and leading global multimedia retailer QVC® to launch Algenist™, Solazyme’s microalgae-based prestige anti-aging skincare line, in the U.S. and internationally. Beginning in March 2011, Algenist will be available on QVC in the U.S. and in over 800 Sephora stores in seven countries throughout Europe and in the US before expanding to Asia and the Middle East. Sephora and QVC will align their powerful promotional efforts behind Algenist in an unprecedented launch.
“We are constantly looking for the latest groundbreaking products to debut to our beauty customer who is both an early adopter and a beauty enthusiast. Algenist is the perfect addition to our growing assortment of premium beauty products.”
Algenist is a line of advanced anti-aging skincare products formulated with Solazyme’s breakthrough ingredient, alguronic acid. Solazyme’s biotechnology scientists unexpectedly discovered alguronic acid, a true breakthrough in the anti-aging market, after studying thousands of microalgae strains for renewable energy solutions. When researched for potential anti-aging benefits, alguronic acid demonstrated significant rejuvenating properties.
International MareLife Innovation Workshop to run a parallel session on second day of The North Atlantic Seafood Forum, Oslo, Norway 3-4. March, 2010
Posted On: February 5, 2010The main objective of the workshop is to provide a meeting place to enhance bio marine innovation through the facilitation of alliances and synergy across otherwise distant sectors and players.
Glycomar receives funding to bring products to nutrition and cosmetics market
Posted On: September 14, 2009An Argyll biotechnology company has been awarded funding from Highlands and Islands Enterprise (HIE) to help launch a number of its products for the commercial market.
Glycomar Ltd, based at Dunstaffnage near Oban, is looking to bring products to market in the fields of both nutrition and cosmetics.
The business has been awarded up to £55,850 towards setting up an 18 month development programme that will build on the success of its research and development of the last three years. The potential products use anti-inflammatory agents to improve joint health and intestinal health and in skin care to promote anti-aging. The development programme will complete the R&D process and bring two new products to market.
Host
 |
Partners
  |
Sponsors
 |
 |
Share Aquapreneur
